Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001415889-24-024622

Options or other derivatives

  • President and CEO acquired 714,184 shares (grant or award)
  • President and CEO returned 714,184 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mack David Henry President and CEO 2024-08-13 Returned to the company · Employee Stock Option (right to buy) −134,584 0 D
Mack David Henry President and CEO 2024-08-13 Returned to the company · Employee Stock Option (right to buy) −249,600 0 D
Mack David Henry President and CEO 2024-08-13 Grant or award · Employee Stock Option (right to buy) +384,184 384,184 D
Mack David Henry President and CEO 2024-08-13 Returned to the company · Employee Stock Option (right to buy) −330,000 0 D
Mack David Henry President and CEO 2024-08-13 Grant or award · Employee Stock Option (right to buy) +330,000 330,000 D
Loading xslF345X05/form4-10032024_081002.xml…